Edronax 4 mg tablete
| Name | Edronax 4 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-843519291 |
| Active Substance | reboksetin metansulfonat |
| Composition | jedna tableta sadrži 4 mg reboksetina u obliku reboksetin metansulfonata |
| Pharmaceutical Form | tableta |
| Manufacturer | Pfizer Italia S.r.l., Ascoli Piceno, Italija |
| Marketing Authorisation Holder | Pfizer Croatia d.o.o., Slavonska avenija 6, Zagreb, Hrvatska |
| Marketing Authorisation Date | 05.04.2016 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/15-02/90 |
| Registration Number | 381-12-01/70-16-09 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N06AX18 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
